Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Zanubrutinib Improved IgG4-Related Disease Outcomes
August 2026
Zanubrutinib monotherapy produced significant imaging, clinical, and immunological improvements in active IgG4-RD, supporting further evaluation as a steroid sparing treatment approach.
Read more
5 Aug 2026
Zanubrutinib Improved IgG4-Related Disease Outcomes
Zanubrutinib monotherapy produced significant imaging, clinical, and immunological improvements in active IgG4-RD, supporting further evaluation as a steroid sparing treatment approach.
3 Aug 2026
Osteoporosis Often Goes Unrecorded After Fragility Fractures
A nationwide Austrian study found that osteoporosis is often not coded alongside fragility fractures, especially upper limb breaks and in men.
31 Jul 2026
Low Medication Adherence in Younger Patients with Behçet's Syndrome
Medication adherence in Behçet’s syndrome was generally satisfactory, but younger patients were more likely to report suboptimal adherence.
27 Jul 2026
Gut-Oral Microbiome Changes Linked to Hand Osteoarthritis
A new study has found that oral microbiome dysbiosis and disrupted oral-gut microbial networks were associated with hand osteoarthritis.
25 Jul 2026
Hip Osteoarthritis Showed No Link with Alcohol Consumption
A retrospective analysis of 87,585 adults found no significant association between alcohol consumption and hip osteoarthritis, while metabolic risk factors and nicotine dependence remained linked to increased disease odds.
24 Jul 2026
Hospital Data Reveals Shifting Face of Rheumatic Disease Care
A nationwide German analysis found that hospitalisation patterns in inflammatory rheumatic diseases have shifted substantially since 2010.
22 Jul 2026
How Obesity Shapes Outcomes in Psoriatic Arthritis
A new review has found that obesity worsens psoriatic arthritis severity and treatment response, calling for more integrated patient care.
20 Jul 2026
Real-World Glucocorticoid Use in Giant Cell Arteritis Remains High
A nationwide study found that glucocorticoid exposure in giant cell arteritis remained substantial, with even low doses linked to serious adverse outcomes.
Loading posts...
1
2
3
…
47
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View